BTAIVSJBIO• 12 Months (Normalized)
BTAI vs JBIO (BioXcel Therapeutics Inc. vs Jade Biosciences Inc.)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-98.5%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
JBIO Performance $17.89
+130.54%
Jade Biosciences Inc.
Normalized Baseline0.00%
Alpha Spread Margin JBIO LEADS
-229.04%
JBIO outperforming by 229.04%
BTAIJBIO
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI JBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BTAI Price | BTAI Gain (%) | JBIO Price | JBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -98.50% | $17.89 | +130.54% | -229.04% |
| Sep 10, 2026 | $0.05 | -98.53% | $19.14 | +146.65% | -245.18% |
| Sep 09, 2026 | $0.05 | -98.61% | $19.06 | +145.62% | -244.23% |
| Sep 08, 2026 | $0.04 | -98.73% | $19.45 | +150.64% | -249.37% |
| Sep 04, 2026 | $0.07 | -97.82% | $19.90 | +156.44% | -254.26% |
| Sep 03, 2026 | $0.12 | -96.52% | $19.85 | +155.80% | -252.32% |
| Sep 02, 2026 | $0.11 | -96.84% | $21.40 | +175.77% | -272.61% |
| Sep 01, 2026 | $0.14 | -95.96% | $21.02 | +170.88% | -266.84% |
| Aug 31, 2026 | $0.16 | -95.19% | $21.36 | +175.26% | -270.45% |
| Aug 28, 2026 | $0.18 | -94.66% | $20.84 | +168.56% | -263.22% |
| Aug 27, 2026 | $0.72 | -78.79% | $21.29 | +174.36% | -253.15% |
| Aug 26, 2026 | $0.78 | -76.99% | $21.33 | +174.87% | -251.86% |
| Aug 25, 2026 | $0.74 | -78.11% | $21.84 | +181.44% | -259.55% |
| Aug 24, 2026 | $0.76 | -77.55% | $21.33 | +174.87% | -252.42% |
| Aug 21, 2026 | $0.80 | -76.28% | $21.34 | +175.00% | -251.28% |
Page 1 of 17